Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $15.2 million.

  • Bio's Cost of Revenue fell 755.83% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.6 million, marking a year-over-year decrease of 767.22%. This contributed to the annual value of $64.6 million for FY2024, which is 832.26% up from last year.
  • Per Bio's latest filing, its Cost of Revenue stood at $15.2 million for Q3 2025, which was down 755.83% from $16.9 million recorded in Q2 2025.
  • In the past 5 years, Bio's Cost of Revenue ranged from a high of $17.5 million in Q1 2024 and a low of $6.3 million during Q1 2021
  • Over the past 5 years, Bio's median Cost of Revenue value was $14.0 million (recorded in 2024), while the average stood at $12.9 million.
  • Per our database at Business Quant, Bio's Cost of Revenue surged by 8195.49% in 2021 and then tumbled by 1868.45% in 2024.
  • Quarter analysis of 5 years shows Bio's Cost of Revenue stood at $8.3 million in 2021, then soared by 40.11% to $11.6 million in 2022, then surged by 47.37% to $17.2 million in 2023, then fell by 18.68% to $14.0 million in 2024, then grew by 9.1% to $15.2 million in 2025.
  • Its Cost of Revenue stands at $15.2 million for Q3 2025, versus $16.9 million for Q2 2025 and $16.6 million for Q1 2025.